Literature DB >> 28382540

Alcohol and cigarette use among adolescents with type 1 diabetes.

Anna M Hogendorf1, Wojciech Fendler2, Janusz Sierosławski3, Katarzyna Bobeff4, Krzysztof Węgrewicz4, Kamila I Malewska4, Maciej W Przudzik4, Małgorzata Szmigiero-Kawko5, Beata Sztangierska5, Małgorzata Myśliwiec5, Agnieszka Szadkowska2, Wojciech M Młynarski2.   

Abstract

In this study, we compare the prevalence of alcohol and cigarette use among Polish adolescents with type 1 diabetes mellitus (T1DM) (n = 209), aged 15-18 years, with that of a large cohort of their healthy peers, using standardized questionnaire used in the European School Survey Project on Alcohol and Drugs (ESPAD). The lifetime, previous year, and past 30-day prevalence of alcohol consumption was high among adolescents with T1DM but lower than in the controls (82.8 vs 92.0%, 71.7 vs 85.6%, and 47.5 vs 69.7%, respectively, p < 10-5). The lifetime and 30-day prevalence of cigarette use was also lower among patients than the controls (54.6 vs 65.5%, p = 0.001 and 27.3 vs 35.9%, p = 0.012, respectively). Patients who admitted smoking exhibited worse metabolic control than non-smokers (p < 0.0001) and had a higher chance of developing diabetic ketoacidosis. The incidence of severe hypoglycemia was higher among those who reported getting drunk in the previous 30 days (p = 0.04) and lifetime smoking (p = 0.01).
CONCLUSIONS: Although alcohol and cigarette consumption is lower than in controls, it is common among teenagers with type 1 diabetes, effecting metabolic control and causing the risk of acute diabetes complications. Better prevention strategies should be implemented in this group of patients in their early teen years. What is Known: • Substance use remains a significant cause of morbidity and mortality among teenagers with type 1 diabetes. • Current medical literature contains inconsistent data on the prevalence of alcohol and cigarette use among adolescents with type 1 diabetes, mostly due to methodological problems with conducting such surveys. What is New: • Methodological approach: we used a validated questionnaire from the European School Survey Project on Alcohol and Other Drugs (ESPAD) and compared the results to a large national control group of 12,114 healthy students who took part in ESPAD in 2011.

Entities:  

Keywords:  Adolescents; Alcohol; Cigarettes; Metabolic control; Type 1 diabetes

Mesh:

Year:  2017        PMID: 28382540     DOI: 10.1007/s00431-017-2895-y

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  34 in total

1.  Impact of smokeless tobacco products on cardiovascular disease: implications for policy, prevention, and treatment: a policy statement from the American Heart Association.

Authors:  Mariann R Piano; Neal L Benowitz; Garret A Fitzgerald; Susan Corbridge; Janie Heath; Ellen Hahn; Terry F Pechacek; George Howard
Journal:  Circulation       Date:  2010-09-13       Impact factor: 29.690

2.  Smoking and arterial stiffness in youth with type 1 diabetes: the SEARCH Cardiovascular Disease Study.

Authors:  Amy S Shah; Dana Dabelea; Jennifer W Talton; Elaine M Urbina; Ralph B D Agostino; R Paul Wadwa; Santica Marcovina; Richard F Hamman; Stephen R Daniels; Lawrence M Dolan
Journal:  J Pediatr       Date:  2014-03-27       Impact factor: 4.406

3.  Day after the night before: influence of evening alcohol on risk of hypoglycemia in patients with type 1 diabetes.

Authors:  Tristan Richardson; Melanie Weiss; Peter Thomas; David Kerr
Journal:  Diabetes Care       Date:  2005-07       Impact factor: 19.112

Review 4.  Smoking rates and the state of smoking interventions for children and adolescents with chronic illness.

Authors:  Vida L Tyc; Leslee Throckmorton-Belzer
Journal:  Pediatrics       Date:  2006-08       Impact factor: 7.124

5.  Emerging adults with type 1 diabetes: a comparison to peers without diabetes.

Authors:  Dianne K Palladino; Vicki S Helgeson; Kerry A Reynolds; Dorothy J Becker; Linda M Siminerio; Oscar Escobar
Journal:  J Pediatr Psychol       Date:  2013-03-07

6.  A nonlinear effect of hyperglycemia and current cigarette smoking are major determinants of the onset of microalbuminuria in type 1 diabetes.

Authors:  L J Scott; J H Warram; L S Hanna; L M Laffel; L Ryan; A S Krolewski
Journal:  Diabetes       Date:  2001-12       Impact factor: 9.461

7.  Adolescents with type 1 diabetes and risky behaviour.

Authors:  Ae Scaramuzza; A De Palma; C Mameli; D Spiri; L Santoro; G V Zuccotti
Journal:  Acta Paediatr       Date:  2010-04-01       Impact factor: 2.299

8.  Beverage intake, diabetes, and glucose control of adults in America.

Authors:  Todd Mackenzie; Blair Brooks; Gerry O'Connor
Journal:  Ann Epidemiol       Date:  2006-02-02       Impact factor: 3.797

9.  Marked smoking-associated increase of cardiovascular risk in childhood type 1 diabetes.

Authors:  Karl Otfried Schwab; Jürgen Doerfer; Kristiane Hallermann; Andreas Krebs; Elisabeth Schorb; Kristin Krebs; Karl Winkler
Journal:  Int J Adolesc Med Health       Date:  2008 Jul-Sep

10.  Tobacco, alcohol, and illicit drug use in adolescents with diabetes mellitus.

Authors:  Alejandro Martínez-Aguayo; Juan Carlos Araneda; Daniela Fernandez; Andrea Gleisner; Virginia Perez; Ethel Codner
Journal:  Pediatr Diabetes       Date:  2007-10       Impact factor: 4.866

View more
  3 in total

1.  Substance Use Among Adolescents and Young Adults With Type 1 Diabetes: Discussions in Routine Diabetes Care.

Authors:  Samantha P Bento; MaryJane S Campbell; Olivia Soutullo; Fran R Cogen; Maureen Monaghan
Journal:  Clin Pediatr (Phila)       Date:  2020-01-31       Impact factor: 1.168

2.  Tobacco use patterns and clinical outcomes in the T1D exchange.

Authors:  Carla J Rash; Sheila M Alessi; Nicole Foster; William Tamborlane; Michelle A Van Name; Julie A Wagner
Journal:  J Diabetes Complications       Date:  2022-01-12       Impact factor: 2.852

3.  The Effects of Risk Behaviors and Orthorexic Behavior on Glycemic Control in Adolescents with Type 1 Diabetes

Authors:  Demet Taş; Eda Mengen; Pınar Kocaay; Seyit Ahmet Uçaktürk
Journal:  J Clin Res Pediatr Endocrinol       Date:  2019-11-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.